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Objective: Although previous series have reported outcomes of lower extremity (LE) revascularization in patients with
end-stage renal disease, the issue of LE bypass for limb salvage in this group has not been resolved. We herein present the
largest series to date of a 10-year single-institution experience with LE bypass in patients with dialysis dependence.
Methods: With prospectively entered data from a university teaching hospital’s vascular registry, we reviewed the records
of all patients with dialysis dependence who underwent LE arterial bypass between January 1, 1990, and May 31, 1999.
Results: A total of 146 consecutive patients (177 limbs) underwent infrainguinal revascularization, of whom nearly all
(92%) had diabetes and tissue loss (91%). The in-hospital mortality rate was 3% (five patients). The rates for perioperative
congestive heart failure, myocardial infarction, arrhythmia, and wound infection were 2%, 3%, 5%, and 10%, respectively.
The actuarial graft primary and secondary patency rates at 1 and 3 years were 84% and 85%, and 64% and 68%,
respectively. The limb salvage rates were 80% and 80% at 1 and 3 years. The 1-year and 3-year cumulative survival rates
were 60% and 18%, respectively. At 5 years, survival was poor with only 5% of the entire cohort of 146 patients still alive.
Multivariate logistic regression analysis at 6 months identified age (odds ratio, 0.96, 0.91) and number of years on dialysis
(odds ratio, 0.79, 0.74) as significant (P < .05) negative predictors of both limb salvage and survival, respectively.
Conclusion: Infrainguinal arterial reconstruction can be performed on patients with dialysis dependence with acceptable
rates of limb salvage given the high incidence rate of perioperative complications and poor longevity of this patient group.
Advanced age and number of years on dialysis seem to correlate with poorer outcome. (J Vasc Surg 2002;36:969-74.)
End-stage renal disease (ESRD), defined as severe im-
pairment of renal function necessitating hemodialysis, peri-
toneal dialysis, or renal transplantation, is known to have
increasing prevalence worldwide.1 Lower extremity (LE)
revascularization in the ESRD population represents a dif-
ficult decision even to the most experienced surgeon. Given
the extent and the severity of atherosclerotic disease asso-
ciated with ESRD, the relative increase in patients with
ESRD who need LE revascularization is not unexpected.
Furthermore, the number of patients with diabetes mellitus
(DM) represents a subset of ESRD that is rapidly growing
as the prevalence of type 2 DM increases globally. Aggres-
sive medical management of DM has allowed these patients
to survive long enough to have ESRD develop.
The surgical literature is unresolved on how best to
manage this subgroup of patients. Many authors are wary
about aggressive revascularization because of poor patient
longevity and significant postoperative morbidity.2-5 Stud-
ies have shown that renal dysfunction adversely affects
outcome for peripheral vascular disease.6,7 Some investiga-
tors recommend primary amputation when certain risk
factors are present.8-10 Others advocate limb salvage strat-
egies because amputation is poorly tolerated in this group
and because limb salvage rates are acceptable when adjusted
for patient survival.11-15 The purpose of this retrospective
study was to determine whether any risk factors exist that
may preclude LE revascularization in patients with dialysis-
dependent ESRD with analysis of our outcome data over
the previous decade.
METHODS
We queried the Vascular Surgery Registry at our insti-
tution and identified 151 consecutive patients with ESRD
who underwent peripheral bypass surgery from January 1,
1990, to May 31, 1999. Every patient medical record was
reviewed by one of the two principal investigators (SR, PR)
to verify the data in the registry. A total of six medical
records were lost, bringing our total to 146 patients (177
limbs). The data in the registry was retrospectively reviewed
but prospectively entered. Patient demographics, risk fac-
tors, cause of renal failure, indications for surgery, proce-
dural details, complications, and follow-up data were sta-
tistically analyzed to determine whether any significant
relationships existed. All dates of death were either ob-
tained from or confirmed with the online Social Security
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Death Index (http://www.ancestry.com/search/rectype/
vital/ssdi/main.htm).
Patients were excluded if they had undergone prior
outflow bypass surgery in that limb or if the renal failure was
not dialysis dependent. Only outflow procedures were re-
viewed; inflow procedures such as aortobifemoral bypasses
were excluded. The two patients with inflow procedures
(aortobifemoral bypass grafts) before infrainguinal bypass
were included in the study. Patients with a history of failed
renal transplantation were included. Patients were included
regardless of conduit or target vessel. General surgery res-
idents or vascular surgery fellows performed all surgeries
under the supervision of a staff vascular surgeon. Bypass
grafts were assessed during routine follow-up in the office
and determined to be patent with either duplex scan,
presence of a palpable graft pulse, presence of a palpable
pulse distal to the graft, or an increase of the ankle-brachial
index of 0.2 above baseline.
Statistics were performed with the aid of Statview 5.0
software (SAS Institute Inc, Cary, NC). Categoric variables
were compared with the 2 test, and continuous variables
with the Student t test. Multivariate logistic regression was
performed with 21 independent variables. Dependent vari-
ables were set as limb salvage past 6 months and survival
longer than 6 months. Independent variables were assumed
to be significant if the Wald test returned a P value less than
.05. Survival rates were calculated with the life-table
method and actuarial analysis. The generalized Wilcoxon
test (Breslow-Gehan-Wilcoxon test) was used to compare
survival curves among different groups. All indications con-
form to the ad hoc Committee of the Joint Council of the
Society of Vascular Surgery.16
RESULTS
Table I lists the demographic data for the 177 limbs in
the study. Each limb was considered as a separate patient
for the purposes of our review. Most patients were white
and male. The average patient age was 63  13 years
(range, 29 to 86 years). Table II identifies preoperative
comorbidities in the study population. Most patients had a
history of smoking, DM, and hypertension. A large propor-
tion of patients had coexistent cardiac disease. Thirty-six
patients (20%) were on warfarin therapy before surgery for
other conditions.
All patients were on hemodialysis before surgery except
for five (3%) who were on peritoneal dialysis. Patients were
on dialysis for an average duration of 2  2 years before
surgery (range, 1 month to 15 years). The causes of ESRD
included DM (88%), hypertension (4%), other (5%), and
unknown (3%). Nine patients (5%) had undergone failed
renal transplantation in the past and had resumed dialysis
before bypass.
Although most patients had more than one indication
for surgery, only the most severe was entered in our data-
base. The overwhelming indication for surgery was critical
ischemia: gangrene (62%), nonhealing ulcer (29%), and rest
pain (9%). An attempt was made to classify ischemic ulcers
and gangrene on the basis of location and presence or
absence of infection (Table III) despite the retrospective
nature of the study. Because most patients received empiric
antimicrobial therapy for ulcer management, the presence
of infection was based on the clinical appearance of the
wound. If the wound was described as cellulitic, foul smell-
ing, or purulent, then it was classified as infected. In addi-
tion, we denoted another variable “I & D” for wounds
requiring incision and debridement or open amputation for
severe infection. Some patients had more than one ulcer.
Given the retrospective nature of the study, no attempt was
made to quantify or qualify the amount of tissue necrosis.
We noted no survival difference in patients with ESRD
with or without heel gangrene. Furthermore, heel gan-
grene did not impact primary graft patency. However, in
our study, a total of 21 limbs (21 patients; 15%) underwent
amputation. Of these, 11 (52%) had patent grafts at the
time of amputation. The presence of heel ulceration signif-
icantly correlated with those patients with patent grafts at
amputation (P  .03).
Table IV summarizes the inflow and outflow locations
for each bypass graft. Eight limbs (5%) underwent sequen-
tial bypass with prosthetic and autologous conduit because
there was not sufficient or adequate autologous conduit to
perform a single bypass. Most proximal anastomoses were
above the knee (81%), and most distal anastomoses were
below the knee (90%). Conduits used were vein (87%),
prosthetic (7%), and composite (6%). Table V represents
the surgical outcome.
Fifty-eight complications affected 41 patients, resulting
in an overall complication rate of 23%. Complications were
subdivided into cardiac, local, and general complications
(Table V). Note that most arrhythmias were not hemody-
namically serious and were composed mostly of supraven-
tricular tachycardia or bradycardia. No patients had either
pulmonary or distal emboli.
The 30-day mortality rate was 5% (total of seven pa-
tients). Two patients died after discharge from the hospital,
presumably of cardiac causes. The causes of death in the
other five included cardiac (n  2), sepsis (n  2), and
mesenteric ischemia. Survival rates (Fig 1) at 1, 3, and 5
years were 60%, 18%, and 5%, respectively. Primary patency
data are illustrated in Fig 2. Primary and secondary patency
rates at 1 and 3 years were 84% and 85%, and 64% and 68%,
respectively. The limb salvagesrates (Fig 3) at 1 and 3 years
were 80% and 80%. With 2 analysis, the presence of
infection, the need for operative debridement, or the pres-
ence of a heel ulcer did not significantly affect survival,
Table I. Patient demographics (n  177)
No.
Male gender 115 (65%)
Race
White 147 (83%)
Black 23 (13%)
Other 7 (4%)
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patency, or limb salvage rates. Stratifying the results into
5-year intervals did not yield any significant difference in
outcomes.
Multivariate logistic regression analysis was performed
at 6 months because not enough patients survived beyond
this time point to identify any meaningful relationships.
Two significant (P  .05) negative predictors of limb
salvage were identified at 6 months: age (odds ratio [OR]
0.96) and years on dialysis (OR  0.79). Three negative
predictors of survival were identified at 6 months: age
(OR  0.91), years on dialysis (OR  0.74), and hyper-
tension (OR  0.13). Location of ulcer, gender, race,
indications for operation, and other preoperative comor-
bidities did not impact significantly on either limb salvage
or survival.
Table II. Preoperative risk factors (n  177)
Smoking DM HTN CAD MI CHF PTCA CABG CVA
No. 113 162 132 115 64 84 21 38 27
Percent 64% 92% 75% 65% 36% 48% 12% 22% 15%
HTN, Hypertension; CAD, coronary artery disease; MI, myocardial infarction; CHF, congestive heart failure; PTCA, percutaneous transluminal coronary
angioplasty; CABG, coronary artery bypass graft; CVA, cerebrovascular accident.
Table III. Characteristics of ischemic tissue loss
No.
Location
Toe 103 (58%)
Foot 21 (12%)
Heel 54 (31%)
Infection 84 (48%)
I & D 33 (19%)
Infection, Clinical signs of infection (cellulitic, foul smelling, purulent); I &
D, requiring prior incision and debridement or subsequent open amputa-
tion.
Table IV. Anatomic location of bypass grafts
Artery Inflow Outflow
Iliac or femoral 123 (70%) 1 (0.6%)
Suprageniculate popliteal 20 (11%) 17 (10%)
Infrageniculate popliteal 34 (19%) 28 (16%)
Tibial 50 (28%)
Dorsalis pedis 80 (45%)
Tarsal 1 (0.6%)
Table V. Complications
No.
Cardiac
Severe cardiac 11 (6%)
Congestive heart failure 5 (3%)
Myocardial infarction 5 (3%)
Cardiac arrest 1 (0.6%)
Arrhythmia 12 (7%)
Local
Wound infection 17 (10%)
Wound necrosis 2 (1%)
Graft infection 2 (1%)
Graft thrombosis 1 (0.6%)
General
Cerebrovascular accident 1 (0.6%)
Sepsis 4 (2%)
Pneumonia 5 (3%)
Upper gastrointestinal bleed 3 (2%)
Fig 1. Actuarial survival rate in 1-month intervals for patients
with ESRD after undergoing LE revascularization over 10-year
period. Standard error less than 10% for entire curve.
Fig 2. Actuarial primary and secondary patency rates in 3-month
intervals of LE bypass grafts in patients with ESRD over 10-year
period. Standard error more than 10% at 30 months for primary
patency and less than 10% for secondary patency for entire curve.
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DISCUSSION
ESRD is a problem that is growing in magnitude. In
the United States Renal Data System (USRDS) annual
report, it was estimated that the number of patients with
dialysis dependence would double between 1998 and
2010. This suggests an absolute increase in patients with
ESRD from approximately 300,000 to 600,000 in 2010.
Because as much as 20% of the ESRD population may
eventually need a vascular consultation, it can be surmised
that an additional 60,000 patients will be considered for LE
revascularization.
The appropriate treatment of ischemic peripheral vas-
cular disease in patients with ESRD has thus far not been
clearly elucidated. Recent reports advocate more limb sal-
vage strategies on the basis of improved morbidity and
mortality data.14,15 Most studies, however, recommend
caution when proceeding with LE revascularization in this
group because of poor patient survival rates ranging from
38% to 62% at 2 years.9,11-13 Indeed, according to the
USRDS (www.usrds.org), the expected survival rate for our
average patient (white, 60 to 64 years old) is 3.6 years. In
addition, the high prevalence of diabetes in our ESRD
population further contributes to diminished survival.
The clinical outcomes of infrainguinal bypass in this
subgroup have varied significantly. On the basis of poor
rates of limb salvage, Edwards, Taylor, and Porter8 con-
cluded that primary amputation might be the treatment of
choice in patients with ischemic ESRD versus attempted
limb salvage via bypass. Other authors have reached similar
conclusions regarding primary amputation on the basis of
the extent of forefoot gangrene and ulceration, particularly
of the heel. Johnson and coworkers9 showed diminished
foot salvage in patients with forefoot gangrene. Similarly,
Leers et al10 noted in their study that patients with heel
gangrene had a higher rate of limb loss and poorer survival.
Several authors have found a relationship between foot
ulceration and major amputation with a patent graft.3,9,17
We noted a similar significant correlation in our study with
heel ulcers in particular, although our numbers are small.
The importance of this relationship is unclear, given this
small subset of patients, but it suggests that there are other
factors besides ischemia responsible for tissue loss in pa-
tients with ESRD and DM. Another explanation for the
low limb salvage rate in this subgroup is that these patients
may present at a more advanced stage of tissue necrosis,
making LE bypass unlikely to succeed. Because the degree
of tissue loss was neither qualified nor quantified in our
database, we cannot offer more specific recommendations.
Recent reports have documented limb salvage rates
between 52% and 87% in patients with ESRD. In our study,
the limb salvage rate was 80% and 80% at 1 and 3 years.
These rates of limb salvage are substantially lower than
those of our general patient population undergoing pedal
bypass who have a limb salvage rate of 87% at 5 years.18
These results suggest that patients with ESRD are less likely
to benefit from arterial reconstruction, although many will,
in spite of obviously severe and diffuse atherosclerotic
disease. Predicting which patients will benefit cannot be
determined from our data. However, it appears as though
certain factors like heel gangrene may be important, on the
basis of our observation that 52% of such patients needed
amputation in spite of patent grafts.
Our primary and secondary patency rates at 1 and 3
years were 84% and 85%, and 64% and 68%, respectively.
These data would suggest that patients might in fact be
dying with a patent graft. These patency rates compare
favorably with data that have been previously published in
other studies.8-11 The argument of conservatism in treating
patients with ESRD on the basis of poor patency rates does
not appear to be consistent with our findings.
The decision to proceed with bypass in patients with
ESRD is further complicated by the increased rates of
perioperative complications and poor long-term survival.
Survival rates in patients with ESRD without peripheral
vascular intervention have been reported at 1, 2, and 5 years
as 75%, 57%, and 30%, respectively, as per the USRDS. Our
results showed poor survival, with 1-year, 2-year, and
5-year survival rates being 60%, 34%, and 5%, respectively,
substantially worse than our survival results in patients
without dialysis dependence requiring bypass whose sur-
vival rates were 65% and 51% at 2 and 4 years, respectively,
in a recent series.19 Our patient population has a selection
bias, with 88% of our patients having ESRD develop from
complications of DM. This disease-based bias may skew our
data with a poorer survival rate versus other contemporary
studies.
Other investigators have evaluated endovascular inter-
ventions as a possible alternative to open infrainguinal
reconstruction.20-22 These authors, however, did not spe-
cifically review outcomes of procedures performed on pa-
tients with ESRD. No author to date has shown either
short-term or long-term results of percutaneous interven-
tions to be better than those of open infrainguinal recon-
struction. Although we have no specific experience, endo-
vascular intervention may be a reasonable alternative to
Fig 3. Actuarial limb salvage rate in 3-month intervals of patients
with ESRD after undergoing LE revascularization over 10-year
period. Standard error more than 10% at 57 months.
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open surgery in patients with ESRD where the anatomic
features of the disease are favorable.
Multiple variables have been evaluated in previous
studies to try and discern those factors responsible for the
increased morbidity and mortality rates in patients with
ESRD. We evaluated the standard risk factors in bypass
surgery, including type of conduit used, patient demo-
graphics, and tobacco use. Analysis of these factors with
multivariate logistic regression revealed several important
relationships at 6 months: age and years on dialysis were
both significant negative predictors of survival and limb
salvage. In addition, the presence of hypertension had a
significant negative impact on survival in this patient group.
Interestingly, the presence of heel ulceration was not a
significant predictor of limb loss.
The data that currently exist on ESRD and infraingui-
nal bypass procedures are controversial. There is no ran-
domized study that could help elucidate the patient with
ESRD most likely to benefit from infrainguinal bypass.
Although limited by our retrospective study, our review
had the benefit of having the largest infrainguinal ESRD
patient population analyzed to date. The most disturbing
aspect of our study was the poor survival rate in this
medically compromised patient population. We believe the
survival data to be accurate because of the basis on the
government’s Social Security Death Index.
Because of the limited life expectancy and the high risk
of perioperative complications in patients with ESRD un-
dergoing LE revascularization, we must improve methods
of patient selection to render a benefit to this subgroup.
Like most studies that evaluate this patient group, our data
suggest that the technical outcome of infrainguinal bypass
grafting in patients with ESRD is satisfactory. However, the
abysmal survival rate may negate the benefit of successful
bypass if patients never achieve a normal functional status
before death because of perioperative complications or
incomplete wound healing. There appears to be a subset of
patients in whom primary amputation is the best treatment
alternative. Age, number of years on dialysis, and hyperten-
sion were identified by this study as negative predictors of
limb salvage and survival. However, these numbers were
significant only at 6 months because of the low numbers of
patients in our study and their poor survivability beyond
that time frame.
Given the disturbingly high mortality and morbidity
rates in this dialysis-dependent subgroup, we believed it
was important to evaluate quality of life data before and
after surgery. Unfortunately, we were unable to contact
sufficient survivors to make statistical analysis possible. The
importance of patient quality of life after surgery cannot be
understated as the mortality data by itself may averse all but
the most aggressive surgeons from operating on patients
with ESRD.
Vascular surgeons must therefore individualize treat-
ment decisions on the basis of clinical circumstances and
their own experience. When in doubt, erring on the side of
arterial reconstruction is appropriate because graft patency
and limb salvage rates are still acceptable. A large multi-
center trial that evaluates the rapidly growing ESRD pop-
ulation with peripheral vascular disease may be the only way
to accurately risk stratify these patients so as to determine
the appropriate procedure.
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